S. 2665 · 115th Congress
A bill to require guidance on how the Food and Drug Administration will consider claims of opioid sparing and on the conditions under which the Food and Drug Administration will consider misuse and abuse of drugs in making certain determinations of safety.
- Stage
- In committee
- Sponsor
- Todd Young
- Introduced
- 2018-04-12
- Latest action
- 2018-04-12 · Introduced in Senate
Subjects
Administrative law and regulatory procedures
Health
Health information and medical records
Drug, alcohol, tobacco use
Department of Health and Human Services
Government information and archives
Prescription drugs
Drug safety, medical device, and laboratory regulation
Food and Drug Administration (FDA)
Drug trafficking and controlled substances
Medical ethics